Roundview Capital LLC - SYNTA PHARMACEUTICALS CORP ownership

Quarter-by-quarter ownership
Roundview Capital LLC ownership history of SYNTA PHARMACEUTICALS CORP
ValueSharesWeighting
Q2 2016$5,0000.0%21,1000.0%0.00%0.0%
Q1 2016$5,000
-28.6%
21,1000.0%0.00%
-33.3%
Q4 2015$7,000
-81.1%
21,1000.0%0.00%
-81.2%
Q3 2015$37,000
-43.1%
21,100
-27.5%
0.02%
-33.3%
Q2 2015$65,000
-18.8%
29,100
-29.2%
0.02%
-25.0%
Q1 2015$80,000
+42.9%
41,100
+94.8%
0.03%
+39.1%
Q4 2014$56,000
-12.5%
21,1000.0%0.02%
-20.7%
Q3 2014$64,000
-25.6%
21,1000.0%0.03%
-17.1%
Q2 2014$86,000
-5.5%
21,1000.0%0.04%
-20.5%
Q1 2014$91,000
-18.0%
21,1000.0%0.04%
-13.7%
Q4 2013$111,000
-16.5%
21,1000.0%0.05%
-26.1%
Q3 2013$133,000
+26.7%
21,1000.0%0.07%
+4.5%
Q2 2013$105,00021,1000.07%
Other shareholders
SYNTA PHARMACEUTICALS CORP shareholders Q3 2023
NameSharesValueWeighting ↓
CAXTON CORP 28,639,349$123,436,00094.21%
Verity Asset Management, Inc. 103,021$456,0000.47%
NBW CAPITAL LLC 242,153$1,044,0000.27%
Old West Investment Management, LLC 69,997$301,0000.19%
IRONWOOD INVESTMENT MANAGEMENT LLC 196,639$848,0000.12%
SOPHROSYNE CAPITAL LLC 25,700$111,0000.10%
Cutler Capital Management, LLC 45,000$194,0000.08%
Rotella Capital Management, Inc. 11,700$50,0000.06%
STONERIDGE INVESTMENT PARTNERS LLC 66,397$286,0000.06%
Roundview Capital LLC 21,100$91,0000.04%
View complete list of SYNTA PHARMACEUTICALS CORP shareholders